Olema Pharmaceuticals, Inc. (OLMA)

23.54 -0.48 (-2.00%) USD  |  NASDAQ  |  Mar 03, 13:27
More

Olema Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for OLMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Cogent Biosciences, Inc. Upgrade
Corvus Pharmaceuticals, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Oric Pharmaceuticals, Inc. Upgrade